Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 9 studies | 27% ± 6% | |
basal cell | 7 studies | 29% ± 9% | |
monocyte | 5 studies | 20% ± 2% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 34% ± 10% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 27% ± 8% | |
ciliated cell | 4 studies | 28% ± 13% | |
CD8-positive, alpha-beta T cell | 4 studies | 17% ± 1% | |
CD8-positive, alpha-beta memory T cell | 4 studies | 22% ± 1% | |
secretory cell | 4 studies | 31% ± 8% | |
fibroblast | 4 studies | 23% ± 4% | |
mucosal invariant T cell | 3 studies | 39% ± 1% | |
myeloid cell | 3 studies | 25% ± 5% | |
epithelial cell | 3 studies | 35% ± 20% | |
club cell | 3 studies | 23% ± 4% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 2% | |
gamma-delta T cell | 3 studies | 31% ± 8% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 25% ± 6% | |
progenitor cell of mammary luminal epithelium | 3 studies | 31% ± 11% | |
mature NK T cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 5 studies | 21% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 96% | 2718.73 | 1381 / 1445 | 100% | 105.48 | 183 / 183 |
lung | 99% | 5388.68 | 574 / 578 | 95% | 40.37 | 1102 / 1155 |
stomach | 93% | 2408.08 | 335 / 359 | 99% | 61.06 | 284 / 286 |
intestine | 94% | 1885.18 | 905 / 966 | 99% | 61.30 | 521 / 527 |
bladder | 95% | 1699.76 | 20 / 21 | 97% | 50.87 | 489 / 504 |
prostate | 98% | 4282.59 | 239 / 245 | 90% | 27.73 | 451 / 502 |
breast | 92% | 2302.86 | 423 / 459 | 86% | 20.60 | 961 / 1118 |
pancreas | 76% | 899.59 | 248 / 328 | 94% | 42.39 | 167 / 178 |
ovary | 69% | 711.02 | 124 / 180 | 89% | 24.25 | 383 / 430 |
kidney | 97% | 1933.92 | 86 / 89 | 54% | 9.38 | 491 / 901 |
liver | 80% | 1525.94 | 181 / 226 | 60% | 13.61 | 244 / 406 |
uterus | 44% | 414.74 | 74 / 170 | 84% | 60.49 | 387 / 459 |
skin | 100% | 4282.77 | 1806 / 1809 | 25% | 4.28 | 118 / 472 |
adrenal gland | 100% | 3041.63 | 258 / 258 | 24% | 3.84 | 56 / 230 |
thymus | 75% | 899.78 | 488 / 653 | 44% | 6.67 | 269 / 605 |
lymph node | 0% | 0 | 0 / 0 | 100% | 39.10 | 29 / 29 |
spleen | 100% | 2108.87 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.80 | 1 / 1 |
peripheral blood | 99% | 3538.52 | 922 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 87.14 | 44 / 45 |
blood vessel | 96% | 1564.62 | 1287 / 1335 | 0% | 0 | 0 / 0 |
adipose | 90% | 2218.03 | 1085 / 1204 | 0% | 0 | 0 / 0 |
heart | 61% | 796.57 | 521 / 861 | 0% | 0 | 0 / 0 |
muscle | 60% | 799.11 | 484 / 803 | 0% | 0 | 0 / 0 |
brain | 5% | 40.92 | 134 / 2642 | 11% | 1.73 | 75 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903936 | Biological process | cellular response to sodium arsenite |
GO_0010468 | Biological process | regulation of gene expression |
GO_0006954 | Biological process | inflammatory response |
GO_1900016 | Biological process | negative regulation of cytokine production involved in inflammatory response |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_1904637 | Biological process | cellular response to ionomycin |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_2000379 | Biological process | positive regulation of reactive oxygen species metabolic process |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0010884 | Biological process | positive regulation of lipid storage |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0002757 | Biological process | immune response-activating signaling pathway |
GO_0061014 | Biological process | positive regulation of mRNA catabolic process |
GO_1900119 | Biological process | positive regulation of execution phase of apoptosis |
GO_0001525 | Biological process | angiogenesis |
GO_0043031 | Biological process | negative regulation of macrophage activation |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0061158 | Biological process | 3'-UTR-mediated mRNA destabilization |
GO_1900745 | Biological process | positive regulation of p38MAPK cascade |
GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
GO_0055118 | Biological process | negative regulation of cardiac muscle contraction |
GO_1903003 | Biological process | positive regulation of protein deubiquitination |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0016579 | Biological process | protein deubiquitination |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_1990869 | Biological process | cellular response to chemokine |
GO_0007399 | Biological process | nervous system development |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0042149 | Biological process | cellular response to glucose starvation |
GO_0044828 | Biological process | negative regulation by host of viral genome replication |
GO_0010587 | Biological process | miRNA catabolic process |
GO_1901223 | Biological process | negative regulation of non-canonical NF-kappaB signal transduction |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0051607 | Biological process | defense response to virus |
GO_0006974 | Biological process | DNA damage response |
GO_0045019 | Biological process | negative regulation of nitric oxide biosynthetic process |
GO_0000184 | Biological process | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO_0098586 | Biological process | cellular response to virus |
GO_0051259 | Biological process | protein complex oligomerization |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_2000320 | Biological process | negative regulation of T-helper 17 cell differentiation |
GO_0030154 | Biological process | cell differentiation |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0006915 | Biological process | apoptotic process |
GO_2000627 | Biological process | positive regulation of miRNA catabolic process |
GO_0010656 | Biological process | negative regulation of muscle cell apoptotic process |
GO_0005856 | Cellular component | cytoskeleton |
GO_0000932 | Cellular component | P-body |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0030867 | Cellular component | rough endoplasmic reticulum membrane |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0004532 | Molecular function | RNA exonuclease activity |
GO_0043022 | Molecular function | ribosome binding |
GO_0004521 | Molecular function | RNA endonuclease activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0035198 | Molecular function | miRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0004540 | Molecular function | RNA nuclease activity |
GO_0003677 | Molecular function | DNA binding |
GO_0035925 | Molecular function | mRNA 3'-UTR AU-rich region binding |
GO_0035613 | Molecular function | RNA stem-loop binding |
Gene name | ZC3H12A |
Protein name | Endoribonuclease ZC3H12A (EC 3.1.-.-) (Monocyte chemotactic protein-induced protein 1) (MCP-induced protein 1) (MCPIP-1) (Regnase-1) (Reg1) (Zinc finger CCCH domain-containing protein 12A) Zinc finger CCCH-type containing 12A |
Synonyms | MCPIP1 MCPIP |
Description | FUNCTION: Endoribonuclease involved in various biological functions such as cellular inflammatory response and immune homeostasis, glial differentiation of neuroprogenitor cells, cell death of cardiomyocytes, adipogenesis and angiogenesis. Functions as an endoribonuclease involved in mRNA decay . Modulates the inflammatory response by promoting the degradation of a set of translationally active cytokine-induced inflammation-related mRNAs, such as IL6 and IL12B, during the early phase of inflammation . Prevents aberrant T-cell-mediated immune reaction by degradation of multiple mRNAs controlling T-cell activation, such as those encoding cytokines (IL6 and IL2), cell surface receptors (ICOS, TNFRSF4 and TNFR2) and transcription factor (REL) (By similarity). Inhibits cooperatively with ZC3H12A the differentiation of helper T cells Th17 in lungs. They repress target mRNA encoding the Th17 cell-promoting factors IL6, ICOS, REL, IRF4, NFKBID and NFKBIZ. The cooperation requires RNA-binding by RC3H1 and the nuclease activity of ZC3H12A (By similarity). Together with RC3H1, destabilizes TNFRSF4/OX40 mRNA by binding to the conserved stem loop structure in its 3'UTR (By similarity). Self regulates by destabilizing its own mRNA (By similarity). Cleaves mRNA harboring a stem-loop (SL), often located in their 3'-UTRs, during the early phase of inflammation in a helicase UPF1-dependent manner . Plays a role in the inhibition of microRNAs (miRNAs) biogenesis . Cleaves the terminal loop of a set of precursor miRNAs (pre-miRNAs) important for the regulation of the inflammatory response leading to their degradation, and thus preventing the biosynthesis of mature miRNAs . Also plays a role in promoting angiogenesis in response to inflammatory cytokines by inhibiting the production of antiangiogenic microRNAs via its anti-dicer RNase activity . Affects the overall ubiquitination of cellular proteins (By similarity). Positively regulates deubiquitinase activity promoting the cleavage at 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains on TNF receptor-associated factors (TRAFs), preventing JNK and NF-kappa-B signaling pathway activation, and hence negatively regulating macrophage-mediated inflammatory response and immune homeostasis (By similarity). Induces also deubiquitination of the transcription factor HIF1A, probably leading to its stabilization and nuclear import, thereby positively regulating the expression of proangiogenic HIF1A-targeted genes . Involved in a TANK-dependent negative feedback response to attenuate NF-kappaB activation through the deubiquitination of IKBKG or TRAF6 in response to interleukin-1-beta (IL1B) stimulation or upon DNA damage . Prevents stress granule (SGs) formation and promotes macrophage apoptosis under stress conditions, including arsenite-induced oxidative stress, heat shock and energy deprivation (By similarity). Plays a role in the regulation of macrophage polarization; promotes IL4-induced polarization of macrophages M1 into anti-inflammatory M2 state (By similarity). May also act as a transcription factor that regulates the expression of multiple genes involved in inflammatory response, angiogenesis, adipogenesis and apoptosis . Functions as a positive regulator of glial differentiation of neuroprogenitor cells through an amyloid precursor protein (APP)-dependent signaling pathway . Attenuates septic myocardial contractile dysfunction in response to lipopolysaccharide (LPS) by reducing I-kappa-B-kinase (IKK)-mediated NF-kappa-B activation, and hence myocardial pro-inflammatory cytokine production (By similarity). .; FUNCTION: (Microbial infection) Binds to Japanese encephalitis virus (JEV) and Dengue virus (DEN) RNAs. .; FUNCTION: (Microbial infection) Exhibits antiviral activity against HIV-1 in lymphocytes by decreasing the abundance of HIV-1 viral RNA species. . |
Accessions | ENST00000640233.1 Q5D1E8 R4GN17 A0A1W2PQC8 C0LED9 ENST00000471012.1 ENST00000373087.7 |